血清学标志物在胃癌诊断中的研究进展
Research Progress of Serological Markers in the Diagnosis of Gastric Cancer
DOI: 10.12677/ACM.2024.141189, PDF,   
作者: 蒲婉秋, 许新才*：新疆医科大学第一附属医院胃肠(肿瘤)外科，新疆 乌鲁木齐
关键词: 胃癌；血清学标志物；诊断；Gastric Cancer； Serological Markers； Diagnosis
摘要: 胃癌(GC)是我国常见的恶性肿瘤之一，其发病率和死亡率均居于我国恶性肿瘤第三位。目前胃癌诊断的金标准是胃镜与活体组织联合检查，但其毕竟为侵入性检查，存在一定痛苦和风险，患者接受程度较差，因此胃镜筛查在人群中的大规模开展受到了限制。用于协助诊断胃癌的方法还有PET-CT，增强CT，肿瘤相关标志物等检查。但其较高的费用及较为繁琐的检查过程使其并不能广泛应用于临床。血清学检查具有非侵入性、微创性的特点，在胃癌诊断检测更加方便、经济、安全，适用于高风险人群筛查，现将血清学指标在胃癌诊断中的研究进展进行综述。
Abstract: Gastric cancer (GC) is one of the common malignant tumors in China, and its incidence and mortality are the third malignant tumors in China. At present, the gold standard for the diagnosis of gastric cancer is the combined examination of gastroscopy and living tissue, but after all, it is an invasive examination, which has certain pain and risk, and the acceptance of patients is poor, so the large-scale development of gastroscopy screening in the population is limited. PET-CT, enhanced CT, tumor related markers and other examinations are also used to assist in the diagnosis of gastric cancer. However, its high cost and cumbersome examination process make it not widely used in clinic. Serological examination has the characteristics of non-invasive and minimally invasive. It is more convenient, economical and safe in the diagnosis and detection of gastric cancer. It is suitable for screening in high-risk population. This paper reviews the research progress of serological indi-cators in the diagnosis of gastric cancer.
文章引用：蒲婉秋, 许新才. 血清学标志物在胃癌诊断中的研究进展[J]. 临床医学进展, 2024, 14(1): 1310-1316. https://doi.org/10.12677/ACM.2024.141189

参考文献

[1] Cao, W., Chen, H.-D., Yu, Y.-W., Li, N. and Chen, W.-Q. (2021) Changing Profiles of Cancer Burden Worldwide and in China: A Secondary Analysis of the Global Cancer Statistics 2020. Chinese Medical Journal, 134, 783-791. [Google Scholar] [CrossRef] 
[2] Xia, C.F., Dong, X.S., Li, H., Cao, M.M., Sun, D.Q., He, S.Y., Yang, F., Yan, X.X., Zhang, S.L., Li, N. and Chen, W.Q. (2022) Cancer Statistics in China and United States, 2022: Profiles, Trends, and Determinants. Chinese Medical Journal, 135, 584-590. [Google Scholar] [CrossRef] 
[3] 高野, 冯拥璞, 刘雨, 等. 新时代消化内镜技术培训和内镜医师培养[J]. 中华消化内镜杂志, 2020(1): 3-10.
[4] 陈玉芳. CEA、CA199、CA724、CA50联合检测诊断胃癌的临床价值[J]. 内蒙古医学杂志, 2021, 53(9): 1101-1102. [Google Scholar] [CrossRef] 
[5] 汪畅. 血清胃蛋白酶原、胃泌素-17和幽门螺杆菌IgG抗体在萎缩性胃炎和早期胃癌诊断中的价值[D]: [硕士学位论文]. 蚌埠: 蚌埠医学院, 2013.
[6] 颜卫荣, 林艳, 马玲敏, 等. 血清胃蛋白酶原联合幽门螺旋杆菌IgG抗体检测在胃癌早期诊断中的应用价值[J]. 中国卫生检验杂志, 2019, 29(11): 1321-1323.
[7] 郭剑, 刘利平. 血清胃蛋白酶原联合Ca724及染色内镜对早期胃癌的诊断意义[J]. 实用癌症杂志, 2018, 33(8): 1319-1322.
[8] Terasawa, T., Nishida, H., Kato, K., Miyashiro, I., Yo-shikawa, T., Takaku, R. and Hamashima, C. (2014) Prediction of Gastric Cancer Development by Serum Pepsinogen Test and Helicobacter pylori Seropositivity in Eastern Asians: A Systematic Review and Meta-Analysis. PLOS ONE, 9, e109783. [Google Scholar] [CrossRef] [PubMed]
[9] Zhu, Y.N., Wang, J., Wang, J., et al. (2023) Applica-tion of Serum Gastric Function Markers and Digestive Tumor Indices to the Diagnosis of Early Gastric Cancer and Pre-cancerous Lesions. Saudi Medical Journal, 44, 795-800. [Google Scholar] [CrossRef] [PubMed]
[10] 孙政, 徐宏涛. 胃蛋白酶原、胃泌素17作为血清学标记物对胃癌初步筛查的价值[J]. 重庆医学, 2019, 48(24): 4202-4205.
[11] Corona, G., Cannizzaro, R., Miolo, G., Caggiari, L., De Zorzi, M., Repetto, O., Steffan, A. and De Re, V. (2018) Use of Metabolomics as a Complementary Omic Approach to Implement Risk Criteria for First-Degree Relatives of Gastric Cancer Patients. International Journal of Molecular Sciences, 19, Article No. 750. [Google Scholar] [CrossRef] [PubMed]
[12] Murphy, G., Abnet, C.C., Choo-Wosoba, H., Vogtmann, E., Weinstein, S.J., Taylor, P.R., Männistö, S., Albanes, D., Dawsey, S.M., Rehfeld, J.F. and Freedman, N.D. (2017) Serum Gastrin and Cholecystokinin Are Associated with Subsequent Development of Gastric Cancer in a Prospective Cohort of Finnish Smokers. International Journal of Epidemiology, 46, 914-923. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, R. and Chen, X.Z. (2020) Prevalence of Atrophic Gastritis in Southwest China and Predictive Strength of Serum Gastrin-17: A Cross-Sectional Study (SIGES). Scientific Reports, 10, Article No. 4523. [Google Scholar] [CrossRef] [PubMed]
[14] Sun, L.P., Guo, X.L., Zhang, Y., Chen, W., Bai, X.L., Liu, J. and Yuan, Y. (2009) Impact of Pepsinogen C Polymorphism on Individual Susceptibility to Gastric Cancer and Its Pre-cancerous Conditions in a Northeast Chinese Population. Journal of Cancer Research and Clinical Oncology, 135, 1033-1039. [Google Scholar] [CrossRef] [PubMed]
[15] 李洪. 血清胃蛋白酶原、胃泌素-17在不同胃疾病中的表达[D]: [硕士学位论文]. 石家庄: 河北医科大学, 2021.[CrossRef] 
[16] 陈卿奇, 羊文芳, 吴素江, 等. 血清胃蛋白酶原及胃泌素-17水平与胃癌的相关性研究[J]. 重庆医学, 2016, 45(35): 4938-4941+4944.
[17] Gašenko, E., Bogdanova, I., Sjomina, O., Aleksandraviča, I., Kiršners, A., Ancāns, G., et al. (2023) Assessing the Utility of Pepsinogens and Gas-trin-17 in Gastric Cancer Detection. European Journal of Cancer Prevention, 32, 478-484. [Google Scholar] [CrossRef] 
[18] Li, Y., Zhao, Y., Li, Y., Zhang, X., Li, C., Long, N., et al. (2021) Gastrin-17 Induces Gastric Cancer Cell Epithelial-Mesenchymal Transition via the Wnt/β-Catenin Signaling Pathway. Journal of Physiology and Biochemistry, 77, 93-104. [Google Scholar] [CrossRef] [PubMed]
[19] Wu, S., Qu, X., Wang, N., Zhang, L., Zhao, X., Wu, Q., Liu, J. and Shi, Y. (2023) MG7-Ag, hTERT, and TFF2 Identified High-Risk Intestinal Metaplasia and Constituted a Prediction Model for Gastric Cancer. Chinese Medical Journal (England), 136, 610-612. [Google Scholar] [CrossRef] 
[20] 赵建芳, 石芳. 血清MG7-Ag联合G-17检测在胃癌诊断中的临床价值[J]. 实用癌症杂志, 2017, 32(12): 1940-1942.
[21] Ocana, A., Nieto-Jiménez, C., Pandiella, A. and Templeton, A.J. (2017) Neutrophils in Cancer: Prognostic Role and Therapeutic Strategies. Molecular Cancer, 16, Arti-cle No. 137. [Google Scholar] [CrossRef] [PubMed]
[22] Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y. and Li, Y. (2021) Inflammation and Tumor Progression: Signaling Pathways and Targeted Intervention. Signal Transduction and Targeted Therapy, 6, Article No. 263. [Google Scholar] [CrossRef] [PubMed]
[23] Franzolin, G. and Tamagnone, L. (2019) Semaphorin Signaling in Cancer-Associated Inflammation. International Journal of Molecular Sciences, 20, Article No. 377. [Google Scholar] [CrossRef] [PubMed]
[24] Zhou, J., Nefedova, Y., Lei, A. and Gabrilovich, D. (2018) Neutrophils and PMN-MDSC: Their Biological Role and Interaction with Stromal Cells. Seminars in Immunology, 35, 19-28. [Google Scholar] [CrossRef] [PubMed]
[25] Leblanc, R. and Peyruchaud, O. (2016) Metastasis: New Func-tional Implications of Platelets and Megakaryocytes. Blood, 128, 24-31. [Google Scholar] [CrossRef] [PubMed]
[26] Eriksen, A.C., Sørensen, F.B., Lindebjerg, J., Hager, H., de-Pont Christensen, R., Kjær-Frifeldt, S. and Hansen, T.F. (2018) The Prognostic Value of Tumor-Infiltrating lymphocytes in Stage II Colon Cancer. A Nationwide Population-Based Study. Translational Oncology, 11, 979-987. [Google Scholar] [CrossRef] [PubMed]
[27] 朱子毓, 汪亦民, 李凤科, 等. 血小板与淋巴细胞比值和中性粒细胞与淋巴细胞比值对TNMⅠ至Ⅲ期胃癌患者的预后评估[J]. 中华消化杂志, 2020(2): 93-98.
[28] Fang, T., Wang, Y., Yin, X., Zhai, Z., Zhang, Y., Yang, Y., et al. (2020) Diagnostic Sensitivity of NLR and PLR in Early Diagno-sis of Gastric Cancer. Journal of Immunology Research, 2020, Article ID: 9146042. [Google Scholar] [CrossRef] [PubMed]
[29] Li, S., Cong, X., Gao, H., Lan, X., Li, Z., Wang, W., Song, S., et al. (2019) Tumor-Associated Neutrophils Induce EMT by IL-17a to Promote Migration and Invasion in Gastric Cancer Cells. Journal of Experimental & Clinical Cancer Research, 38, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[30] Zhang, Y., Hu, Y., Ma, C., Sun, H., Wei, X., Li, M., Wei, W., Zhang, F., Yang, F., Wang, H. and Gu, K. (2020) Diagnostic, Therapeutic Predictive, and Prognostic Value of Neutro-phil Extracellular Traps in Patients with Gastric Adenocarcinoma. Frontiers in Oncology, 10, Article No. 1036. [Google Scholar] [CrossRef] [PubMed]
[31] Olsson, A.K. and Cedervall, J. (2018) The Pro-Inflammatory Role of Platelets in Cancer. Platelets, 29, 569-573. [Google Scholar] [CrossRef] [PubMed]
[32] Jiang, Y., Xu, H., Jiang, H., Ding, S. and Zheng, T. (2016) Pretreatment Neutrophil-Lymphocyte Count Ratio May Associate with Gastric Cancer Presence. Cancer Biomarkers, 16, 523-528. [Google Scholar] [CrossRef] 
[33] Müller, I., Munder, M., Kropf, P. and Hänsch, G.M. (2009) Polymorphonuclear Neutrophils and T Lymphocytes: Strange Bedfellows or Brothers in Arms? Trends in Immunology, 30, 522-530. [Google Scholar] [CrossRef] [PubMed]
[34] Xu, Y., Zhang, P., Zhang, K. and Huang, C. (2021) The Application of CA72-4 in the Diagnosis, Prognosis, and Treatment of Gastric Cancer. Biochimica et Biophysica Acta (BBA)—Reviews on Cancer, 1876, Article ID: 188634. [Google Scholar] [CrossRef] [PubMed]
[35] Hu, P.J., Chen, M.Y., Wu, M.S., Lin, Y.C., Shih, P.H., Lai, C.H. and Lin, H.J. (2019) Clinical Evaluation of CA72-4 for Screening Gastric Cancer in a Healthy Population: A Multicenter Retrospective Study. Cancers (Basel), 11, Article No. 733. [Google Scholar] [CrossRef] [PubMed]
[36] Byrne, D.J., Browning, M.C. and Cuschieri, A. (1990) CA72-4: A New Tumour Marker for Gastric Cancer. British Journal of Surgery, 77, 1010-1013. [Google Scholar] [CrossRef] [PubMed]
[37] Kim, J.H., Jun, K.H., Jung, H., Park, I.S. and Chin, H.M. (2014) Prognostic Value of Preoperative Serum Levels of Five Tumor Markers (Carcinoembryonic An-tigen, CA19-9, Alpha-Fetoprotein, CA72-4, and CA125) in Gastric Cancer. Hepatogastroenterology, 61, 863-869.
[38] 周宇, 陈蓉, 夏先根. CEA联合sHLA-G、PG、DKK-1在胃癌早期诊断及淋巴结转移预测中的临床价值[J]. 华南国防医学杂志, 2020, 34(5): 314-317. [Google Scholar] [CrossRef] 
[39] 凤敏华, 姚立军, 翁莲英, 等. 血清肿瘤标志物的联合检测在胃癌诊断中的价值[J]. 国际检验医学杂志, 2009, 30(10): 950-951+954.
[40] 杨莉, 李晓南, 杨晓雪. 血清肿瘤标志物CEA、CA19-9及CA724联合检测在胃癌诊断中的价值分析[J]. 临床和实验医学杂志, 2020, 19(4): 387-391.
[41] 高文华, 付勇, 周萍, 等. CD147、CEA在胃癌组织中的表达及预后价值[J]. 现代肿瘤医学, 2016, 24(17): 2750-2754.
[42] 易伟莲, 揭育丽, 袁汉尧. 血清CEA, CA50和TGF-α水平测定对胃癌的诊断价值[J]. 广东医学, 2001(1): 40-41. [Google Scholar] [CrossRef] 
[43] Ballehaninna, U.K. and Chamberlain, R.S. (2012) The Clinical Utility of Serum CA 19-9 in the Diagnosis, Prognosis and Management of Pancreatic Adenocarcinoma: An Evi-dence Based Appraisal. Journal of Gastrointestinal Oncology, 3, 105-119.
[44] 蔡晓娟, 王堃, 喻晶. 异常凝血酶原联合CEA、CA72-4和CA199在胃癌诊治中的价值[J]. 肿瘤防治研究, 2018, 45(6): 395-399.

为你推荐